Katalog der Deutschen Nationalbibliothek

Go to:

Catalogue (Beta)

Knowledge Web

Person
Person

Person

Roland E. Schmieder

Arzt

Name

Roland E. Schmieder

Place

Erlangen (Wirkungsort)
Deutschland

Academic degree

Prof. Dr. med.

Profession

Arzt (characteristic profession)

Record type

Person

GND-Identifier

112867073

Record ID

112867073

Involved in

show all

Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial

Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial

Is GFR decline induced by SGLT2 inhibitor of clinical importance?

Correction: Cost Effectiveness of Endovascular Ultrasound Renal Denervation in Patients with Resistant Hypertension

Cost Effectiveness of Endovascular Ultrasound Renal Denervation in Patients with Resistant Hypertension

36-month durability of ultrasound renal denervation for hypertension resistant to combination therapy in RADIANCE-HTN TRIO

Skin sodium content as a predictor of blood pressure response to renal denervation

Afferent neurons of the kidney with impaired firing pattern in inflammation – role of sodium currents?

Angiotensin pathways under therapy with empagliflozin in patients with chronic heart failure

Determinants of arterial stiffness in patients with type 2 diabetes mellitus: a cross sectional analysis

Is vascular remodelling in patients with chronic heart failure exaggerated?

Myocardial infarction with a preserved ejection fraction—the impaired function of the cardio-renal baroreflex

The SGLT2 inhibitor empagliflozin reduces tissue sodium content in patients with chronic heart failure: results from a placebo-controlled randomised trial

Long-term reduction in morning and nighttime blood pressure after renal denervation: 36-month results from SPYRAL HTN-ON MED trial

Change of renal function after short-term use of cardioprotective agents in patients with type 2 diabetes is not accurately assessed by the change of estimated glomerular filtration rate: an observational study

Hypertension urgencies in the SPYRAL HTN-OFF MED Pivotal trial

Association between exercise frequency with renal and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk

Effects of treatment with SGLT-2 inhibitors on arginine-related cardiovascular and renal biomarkers

Association between exercise frequency with renal and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk

Association between exercise frequency with renal and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk

Cardiovascular risk reduction after renal denervation according to time in therapeutic systolic blood pressure range

Editorial comment: Renal denervation

Effects of cardiovascular single pill combinations compared with identical multi-pill therapies on healthcare cost and utilization in Germany

Effects of treatment with SGLT-2 inhibitors on arginine-related cardiovascular and renal biomarkers

Renal hemodynamic effects differ between antidiabetic combination strategies: randomized controlled clinical trial comparing empagliflozin/linagliptin with metformin/insulin glargine

Kriterien der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e. V. (DGK), der Deutschen Hochdruckliga e. V. DHL®/Deutschen Gesellschaft für Hypertonie und Prävention und der Deutschen Gesellschaft für Nephrologie (DGfN) zur Zertifizierung von „Renale-Denervations-Zentren (RDZ)“ – Update

Responsiveness of afferent renal nerve units in renovascular hypertension in rats

Sex-specific differences and long-term outcome of patients with coronary artery disease and chronic kidney disease: the Coronary Artery Disease and Renal Failure (CAD-REF) Registry

Predictors of blood pressure response to ultrasound renal denervation in the RADIANCE-HTN SOLO study

Update on Treatment of Hypertension After Renal Transplantation

AT II Receptor Blockade and Renal Denervation: Different Interventions with Comparable Renal Effects?

Association of Noise Annoyance with Measured Renal Hemodynamic Changes

Detection of Changes in Renal Blood Flow Using Arterial Spin Labeling MRI

Effects of the sodium-glucose cotransporter 2 inhibitor empagliflozin on vascular function in patients with chronic heart failure

Hypertrophic remodelling of retinal arterioles in patients with congestive heart failure

Neurogenic substance P—influences on action potential production in afferent neurons of the kidney?

Renal and intraglomerular haemodynamics in chronic heart failure with preserved and reduced ejection fraction

Sex-specific differences and long-term outcome of patients with coronary artery disease and chronic kidney disease: the Coronary Artery Disease and Renal Failure (CAD-REF) Registry

Effect of renal denervation in attenuating the stress of morning surge in blood pressure: post-hoc analysis from the SPYRAL HTN-ON MED trial

Correction to: Rationale and design of two randomized sham‑controlled of catheter‑based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN‑OFF MED Pivotal) and presence (SPYRAL HTN‑ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design

Rationale and design of two randomized sham-controlled trials of catheter-based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN-OFF MED Pivotal) and presence (SPYRAL HTN-ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design

Facing the Challenge of Lowering Blood Pressure and Cholesterol in the Same Patient: Report of a Symposium at the European Society of Hypertension

Renal denervation in high-risk patients with hypertension

Patient preference for therapies in hypertension: a cross-sectional survey of German patients

How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical trial

Effects of renal denervation on blood pressure in hypertensive patients with end-stage renal disease: a single centre experience

How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical trial

Early vascular parameters in the micro- and macrocirculation in type 2 diabetes

Correction to: Percutaneous Creation of a Central Iliac Arteriovenous Anastomosis for the Treatment of Arterial Hypertension

Percutaneous Creation of a Central Iliac Arteriovenous Anastomosis for the Treatment of Arterial Hypertension

SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial

Early vascular parameters in the micro- and macrocirculation in type 2 diabetes

Left Ventricular Structure in Patients With Mild-to-Moderate CKD : a Magnetic Resonance Imaging Study

Impact of renal denervation on tissue Na+ content in treatment-resistant hypertension

A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation

A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation

Effects of linagliptin on renal endothelial function in patients with type 2 diabetes: a randomised clinical trial

Auf den richtigen „Augenblick“ kommt es an

Non-invasive Renal Denervation: Update on External Ultrasound Approaches

Renal denervation in hypertensive patients not on blood pressure lowering drugs
Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

DNB portal